Review: Chemoembolization for liver metastases from medullary thyroid carcinoma

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 7, 2006, Pages 2496-2499

  Fromigue J ^a   De Baere, T ^a   Baudin, E ^a   Dromain, C ^a   Leboulleux, S ^a   Schlumberger, M ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; DOXORUBICIN; IODINATED POPPYSEED OIL; LIVER ENZYME; CALCITONIN;

ABDOMINAL PAIN; ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ADULT; AGED; ARTICLE; CHEMOEMBOLIZATION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIARRHEA; FEMALE; FEVER; HUMAN; LIVER METASTASIS; MALE; NAUSEA; PRIORITY JOURNAL; RADIOLOGY; SIDE EFFECT; SYMPTOM; THYROID MEDULLARY CARCINOMA; TREATMENT DURATION; TREATMENT RESPONSE; TUMOR NECROSIS; VOMITING; BLOOD; CASE REPORT; LIVER; LIVER TUMOR; MEDULLARY CARCINOMA; METASTASIS; METHODOLOGY; MIDDLE AGED; RADIOGRAPHY; REVIEW; THYROID TUMOR; TREATMENT OUTCOME; VASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; CALCITONIN; CARCINOEMBRYONIC ANTIGEN; CARCINOMA, MEDULLARY; CHEMOEMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; THYROID NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 33745775891     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2005-2401     Document Type: Article

References (21)

1. Ball DW, Baylin SB, De Butros AC 2000 Medullary thyroid carcinoma. In: Braverman LE, Utiger RD, eds. Werner and Ingbar's the thyroid. 8th ed. Philadelphia: Lippincott Williams and Wilkins; 930-943
2. Gagel RF, Marx SJ 2002 Multiple endocrine neoplasia. In: Larsen PR, Kronenberg HM, Melmed S, Polonsky KS, eds. Williams textbook of endocrinology. 10th ed. Philadelphia: Saunders; 1717-1762
3. Dottorini ME, Assi A, Sironi M, Sangalli G, Spreafico G, Colombo L 1996 Multivariate analysis of patients with medullary thyroid carcinoma. Prognostic significance and impact on treatment of clinical and pathologic variables. Cancer 77:1556-1565
4. Shimaoka K, Schoenfeld DA, De Wys WD, Greech RH, De Conti RA 1985 A randomized trial of Doxorubicin versus Doxorubicin plus Cisplatin in patients with advanced thyroid carcinoma. Cancer 56:2155-2160
5. Petursson SR 1988 Metastatic medullary thyroid carcinoma: complete response to combination chemotherapy with dacarbazine and 5 fluorouracil. Cancer 62:1899-1903
6. Williams SD, Birch R, Einhorn LH 1986 Phase II evaluation of doxorubicin plus cisplatin in advanced thyroid cancer: a Southeastern cancer study group trial. Cancer Treat Rep 70:405-407
7. Hoskin PJ, Harmer C 1987 Chemotherapy for thyroid cancer. Radiother Oncol 10:187-194
8. Wu LT, Averbuch SD, Ball DW, De Bustros A, Baylin SB, Mac Guire III WP 1994 Treatment of advanced medullary thyroid carcinoma with a combination of cyclophosphamide, vincristine and dacarbazine. Cancer 73:432-436
9. Orlandi F, Caraci P, Berruti A, Puligheddu B, Pivano G, Dogliotti L, Angeli A 1994 Chemotherapy with dacarbazine and 5-fluorouracil in advanced medullary thyroid cancer. Ann Oncol 5:763-765
10. Schlumberger M, Abdelmoumene N, Delisle MJ, Couette JE 1995 Treatment of advanced medullary thyroid cancer with an alternating combination of 5 FU-streptozocin and 5 FU-dacarbazine. The Groupe d'Etude des Tumeurs a Calcitonine (GETC). Br J Cancer 71:363-365
11. Nocera M, Baudin E, Pellegriti G, Cailleux AF, Mechelany-Corone C, Schlumberger M 2000 Treatment of advanced medullary thyroid cancer with an alternating combination of doxorubicin-streptozocin and 5 FU-dacarbazine. Br J Cancer 83:715-718
12. Modigliani E, Cohen R, Joannidis S, Siame-Mourot C, Guliana JM, Charpentier G, Cassuto D, Bentata-Pessayre M, Tabarin A, Roger P, Caron P, Guillausseau PJ, Lalau JD, Tourniaire J, Bayard F, Aufevre P, James-Deider A, Calmettes C 1992 Results of long-term continuous subcutaneous octreotide administration of 14 patients with medullary thyroid carcinoma. Clin Endocrinol (Oxf) 36:183-186
13. Berber E, Flesher N, Siperstein AE 2002 Laparoscopic radiofrequency ablation of neuroendocrine liver metastases. World J Surg 26:985-990
14. Kebebew E, Ituarte PHG, Siperstein AE, Duh QY, Clark OH 2000 Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems. Cancer 88:1139-1148
15. Therasse E, Breittmayer F, Roche A, De Baere T, Indushekar S, Ducreux M, Lasser P, Elias D, Rougier P 1993 Transcatheter chemoembolization of progressive carcinoid liver metastasis. Radiology 189:541-547
16. Isozaki T, Kiba T, Numata K, Saito S, Shimamura T, Kitamura T, Morita K, Tanaka K, Sekihara H 1999 Medullary thyroid carcinoma with multiple hepatic metastases: treatment with transcatheter arterial embolization and percutaneous ethanol injection. Intern Med 38:17-21
17. Lorenz K, Brauckhoff M, Behrmann C, Sekulla C, Ukkat J, Brauckhoff K, Gimm O, Dralle H 2005 Selective arterial chemoembolization for hepatic metastases from medullary thyroid carcinoma. Surgery 138:986-993
18. Machens A, Behrmann C, Dralle H 2000 Chemoembolization of liver metastases from medullary thyroid carcinoma. Ann Int Med 132:596-597
19. Roche A, Girish BV, de Baere T, Baudin E, Boige V, Elias D, Lasser P, Schlumberger M, DucreuxM2003 Trans-catheter arterial chemoembolization as first-line treatment for hepatic metastases from endocrine tumors. Eur J Radiol 13:136-140
20. Skinazi F, Zins M, Menu Y, Bernades P, Ruszniewski P 1996 Liver metastases of digestive endocrine tumours: natural history and response to medical treatment. Eur J Gastroenterol Hepatol 8:673-678
21. Roche A, Girish BV, de Baere T, Ducreux M, Elias D, Laplanche A, Boige V, Schlumberger M, Ruffie P, Baudin E 2004 Prognostic factors for chemoembolization in liver metastasis from endocrine tumors. Hepato Gastro Enterol 51:1751-1756